{"id":4530,"date":"2026-11-09T06:59:20","date_gmt":"2026-11-09T06:59:20","guid":{"rendered":"https:\/\/www.jsdpharma.com\/?p=4530"},"modified":"2026-11-09T07:00:28","modified_gmt":"2026-11-09T07:00:28","slug":"biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products","status":"publish","type":"post","link":"https:\/\/www.jsdpharma.com\/pt-br\/blog\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\/","title":{"rendered":"Biologics and Specialty Injectables: How Closure Requirements Differ from Standard LVP Products"},"content":{"rendered":"<h2>Why Biologics Require Different Pharmaceutical Closure Solutions<\/h2>\n<p>Not all injectable pharmaceutical products place the same demands on their packaging. Biologics and specialty injectables often require more stringent closure specifications than conventional large-volume parenteral (LVP) products because of their molecular complexity, sensitivity to environmental conditions, and specialized manufacturing processes.<\/p>\n<p>Traditional LVP products, such as sodium chloride and glucose solutions, generally have relatively simple formulations and established storage and sterilization processes. By contrast, many biologics contain peptides, proteins, or other complex molecules whose structures and biological activity can be sensitive to temperature, chemical interactions, and changes in formulation conditions.<\/p>\n<p>These differences directly influence the selection of pharmaceutical closures. Material purity, extractables and leachables, low-temperature performance, dimensional precision, sterilization compatibility, and container closure integrity can all become critical considerations.<\/p>\n<p>For pharmaceutical manufacturers, understanding these differences is essential when selecting rubber stoppers, elastomeric seals, and other packaging components for injectable drug products.<\/p>\n<h2>1. Biologics and Specialty Injectables: Material Purity and Product Compatibility<br \/>\n<img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-4259\" src=\"https:\/\/www.jsdpharma.com\/wp-content\/uploads\/2026\/11\/4.-Biologics-and-Specialty-Injectables-Inner-1.jpg\" alt=\"Close-up of a machine featuring a prominent metal ring, showcasing intricate details and mechanical components.\" width=\"1200\" height=\"600\" srcset=\"https:\/\/www.jsdpharma.com\/wp-content\/uploads\/2026\/11\/4.-Biologics-and-Specialty-Injectables-Inner-1.jpg 1200w, https:\/\/www.jsdpharma.com\/wp-content\/uploads\/2026\/11\/4.-Biologics-and-Specialty-Injectables-Inner-1-300x150.jpg 300w, https:\/\/www.jsdpharma.com\/wp-content\/uploads\/2026\/11\/4.-Biologics-and-Specialty-Injectables-Inner-1-1024x512.jpg 1024w, https:\/\/www.jsdpharma.com\/wp-content\/uploads\/2026\/11\/4.-Biologics-and-Specialty-Injectables-Inner-1-768x384.jpg 768w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\" \/><\/h2>\n<p>Biologics often contain complex active substances that may be sensitive to their surrounding environment. Depending on the product, storage requirements may include refrigeration or frozen conditions, while some formulations also require protection against oxidation, moisture, or other environmental influences.<\/p>\n<p>As a result, pharmaceutical closures used for biologics must be carefully evaluated for their compatibility with the drug product. Particular attention should be given to substances that may migrate from packaging materials into the formulation, including oligomers, antioxidants, degradation products, metal ions, and residual solvents where relevant.<\/p>\n<p>Extractables and leachables studies help characterize these potential interactions. Extractables testing evaluates substances that can be released under specified laboratory extraction conditions, while leachables studies investigate compounds that migrate into the drug product or an appropriate representative medium under relevant storage and use conditions.<\/p>\n<p>For sensitive biologics, the resulting data must be assessed against the formulation&#8217;s characteristics, intended storage conditions, patient exposure, and applicable safety requirements.<\/p>\n<p>High-purity materials and well-controlled formulations can help reduce potential sources of unwanted chemical substances. Where appropriate, coated pharmaceutical closures may also be considered to help control interactions between the closure material and the drug product.<\/p>\n<p>However, coating selection must be supported by biologics-drug compatibility data and suitable performance testing. The objective is to select a closure system that maintains drug quality throughout the product&#8217;s intended shelf life.<\/p>\n<h2>2. Sterility Assurance and Specialized Manufacturing Requirements<\/h2>\n<p>Many biologics cannot undergo conventional terminal sterilization because the required sterilization conditions may adversely affect the active ingredient. These products therefore commonly rely on aseptic manufacturing processes, although the appropriate approach depends on the specific formulation and validated manufacturing strategy.<\/p>\n<p>This places additional demands on the pharmaceutical closure system. Closures must be compatible with the selected sterilization or preparation process and suitable for use within the product&#8217;s aseptic manufacturing environment.<\/p>\n<p>Depending on the application, rubber stoppers and other elastomeric components may require validated sterilization before use. Manufacturers must also consider particulate control, bioburden, endotoxin limits, packaging integrity, and the controls necessary to maintain the required level of sterility assurance.<\/p>\n<p>For biologics and specialty injectables, closure selection should therefore be integrated into the broader manufacturing and contamination-control strategy rather than treated as an isolated packaging decision. This is why choosing the best <a href=\"https:\/\/www.jsdpharma.com\/pt-br\/\">pharmaceutical packaging supplier<\/a> is key to a sterile product line.<\/p>\n<h2>3. Lyophilized Biologics: Moisture Control and Specialized Closure Design<\/h2>\n<p>Lyophilization, or freeze-drying, is widely used for pharmaceutical products that benefit from reduced moisture content and improved storage stability. Many biologics and specialty injectables are supplied in lyophilized form and require specialized closures designed to accommodate the freeze-drying process.<\/p>\n<p>Lyophilized products may use stoppers with specific geometries, including vented or slotted designs, that allow water vapor to escape during drying while supporting subsequent container closure integrity when the closure is fully seated.<\/p>\n<p>The closure must be compatible with the lyophilization cycle and the final sealing process. Moisture control is particularly important because residual moisture can influence the stability of the dried formulation. The complete packaging system must also provide suitable protection against moisture ingress during storage.<\/p>\n<p>Material selection, stopper geometry, sealing compression, and the performance of the final container closure system all contribute to the suitability of a closure for lyophilized products.<\/p>\n<p>For pharmaceutical manufacturers developing freeze-dried biologics, choosing a closure specifically suited to the process can help support product stability and reliable long-term storage.<\/p>\n<h2>4. Prefilled Syringes and Cartridges: Precision Beyond Conventional Vial Closures<\/h2>\n<p>An increasing range of biologics and specialty injectable products is supplied in prefilled syringes and cartridge-based delivery systems. Unlike conventional vial closures, these systems may require elastomeric components to perform multiple functions, including sealing, controlled movement, and compatibility with the drug formulation and delivery device.<\/p>\n<p>For example, a syringe plunger stopper must maintain an effective seal while moving smoothly through the barrel during administration. Cartridge closures may likewise require a balance between sealing performance, sliding behavior, and compatibility with the delivery mechanism.<\/p>\n<p>These applications place demanding requirements on dimensional accuracy, friction, material consistency, and component compatibility. For example, the diameter tolerance may need to be controlled within \u00b10.1 mm, with an interference fit of 0.5%\u20131.2%, depending on the specific design and application. These requirements are at least twice as stringent as those typically applied to conventional large-volume parenteral (LVP) rubber stoppers. Even small variations in dimensions or mechanical properties can affect assembly, break-loose force, glide force, and overall device performance.<\/p>\n<p>Dimensional tolerances must therefore be established according to the specific component design and validated manufacturing requirements. Requirements for a prefilled syringe or cartridge should not automatically be transferred from conventional LVP rubber stoppers because the components perform different functions.<\/p>\n<p>For manufacturers developing combination products or specialized injectable delivery systems, closure selection must account for both pharmaceutical compatibility and device functionality.<\/p>\n<h2>5. Low-Temperature Performance and Coated Pharmaceutical Closures<br \/>\n<img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-4261\" src=\"https:\/\/www.jsdpharma.com\/wp-content\/uploads\/2026\/11\/4.-Biologics-and-Specialty-Injectables-Inner-2.jpg\" alt=\"Two individuals in lab coats and masks collaborate on a tablet in a laboratory setting.\" width=\"1200\" height=\"600\" srcset=\"https:\/\/www.jsdpharma.com\/wp-content\/uploads\/2026\/11\/4.-Biologics-and-Specialty-Injectables-Inner-2.jpg 1200w, https:\/\/www.jsdpharma.com\/wp-content\/uploads\/2026\/11\/4.-Biologics-and-Specialty-Injectables-Inner-2-300x150.jpg 300w, https:\/\/www.jsdpharma.com\/wp-content\/uploads\/2026\/11\/4.-Biologics-and-Specialty-Injectables-Inner-2-1024x512.jpg 1024w, https:\/\/www.jsdpharma.com\/wp-content\/uploads\/2026\/11\/4.-Biologics-and-Specialty-Injectables-Inner-2-768x384.jpg 768w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\" \/><\/h2>\n<p>Many biologics require refrigerated or frozen storage, making temperature compatibility an important factor in closure selection. Elastomeric materials must maintain their required sealing and mechanical properties under the intended storage and handling conditions.<\/p>\n<p>Low-temperature evaluation may include dimensional stability, elasticity, compression behavior, sealing performance, and resistance to cracking or other material changes, as appropriate for the application.<\/p>\n<p>Coated closures may also be considered when reduced direct contact between the elastomer and drug formulation is desirable. Depending on the coating system, these closures may help control surface interactions, reduce certain extractables or leachables, or improve functional performance.<\/p>\n<p>Nevertheless, coating does not automatically guarantee lower extractables, improved compatibility, or superior sealing. These benefits must be demonstrated through application-specific testing, including evaluation of coating integrity and performance throughout the intended storage and use conditions.<\/p>\n<p>For biologics, the preferred closure should be selected based on demonstrated compatibility with the drug product, temperature requirements, manufacturing process, and container design.<\/p>\n<h2>6. Standard LVP Products: Sealing, Heat Resistance, and Cost Efficiency<\/h2>\n<p>Conventional large-volume parenteral products commonly include sodium chloride solutions, glucose solutions, and other relatively simple aqueous formulations. Compared with many biologics, these products generally have less complex compositions and may be compatible with established terminal sterilization processes.<\/p>\n<p>As a result, closure selection for standard LVP products often places greater emphasis on reliable sealing, heat resistance, manufacturing consistency, and cost efficiency.<\/p>\n<p>Where high-temperature terminal sterilization is used, closures must withstand the applicable temperature, pressure, and cycle duration without unacceptable changes in mechanical properties or sealing performance. Compatibility with the container and resistance to sticking or adhesion after sterilization is one of the most important considerations.<\/p>\n<p>Extractables and leachables requirements remain relevant to LVP packaging. However, the appropriate testing scope and acceptance criteria depend on the formulation, material, route of administration, exposure conditions, and applicable regulatory requirements. Simple formulations do not eliminate the need for a scientifically justified compatibility assessment.<\/p>\n<p>For many standard LVP applications, conventional elastomeric materials may provide suitable performance when their specifications, sterilization compatibility, and container closure integrity have been appropriately demonstrated.<\/p>\n<h2>7. How to Select the Right Pharmaceutical Closure for Your Injectable Product<\/h2>\n<p>Selecting a pharmaceutical closure begins with understanding the drug product and its manufacturing requirements. For biologics, this may involve evaluating molecular sensitivity, storage temperature, sterilization strategy, extractables and leachables, and the possibility of adsorption or other interactions with the packaging material.<\/p>\n<p>For lyophilized products, the evaluation should also consider vapor transfer during freeze-drying, residual moisture requirements, and the performance of the final sealed container. For prefilled syringes and cartridges, dimensional tolerances, friction characteristics, and drug delivery-device compatibility become additional priorities.<\/p>\n<p>For standard LVP products, the focus may be on sealing reliability, terminal sterilization resistance, consistent production quality, and cost-effective manufacturing.<\/p>\n<p>In every case, the selected closure should be supported by appropriate technical documentation and validation data. Relevant evidence may include material specifications, certificates of analysis, chemical characterization, biological safety evaluations, functional test results, and container closure integrity studies, as applicable.<\/p>\n<p>A structured selection process helps pharmaceutical manufacturers align closure performance with product quality requirements while avoiding unnecessary technical complexity or cost.<\/p>\n<h2>Advancing Pharmaceutical Closure Solutions with JSD Pharma<\/h2>\n<p>The growing use of biologics, specialty injectables, and advanced drug delivery systems is creating new demands for pharmaceutical packaging materials and closure engineering.<\/p>\n<p>JSD Pharma develops pharmaceutical packaging components with attention to material performance, product design, manufacturing consistency, and application-specific requirements. Understanding the differences between biologics and conventional LVP products is an important step toward selecting suitable closure solutions for each application.<\/p>\n<p>To address the evolving needs of biologics packaging, JSD Pharma is actively developing JSD141, a new form of TPE material designed to be used with spray coating. This material is being developed for potential application to pharmaceutical packaging components used in biologics, offering another approach to material and surface engineering for specialized drug delivery applications.<\/p>\n<p>Whether the priority is biologics-drug chemical compatibility, specialized lyophilization closure design, low-temperature performance, precision sealing, or heat resistance for conventional LVP products, the right solution begins with a clear understanding of the drug product and its manufacturing process.<\/p>\n<p><a href=\"https:\/\/www.jsdpharma.com\/pt-br\/\">JSD Pharma<\/a> supports pharmaceutical packaging development through technical collaboration and application-focused engineering, helping manufacturers evaluate closure solutions against their specific quality, performance, and production requirements with <a href=\"https:\/\/www.jsdpharma.com\/pt-br\/product-category\/medical-grade-tpe-products\/\">medical-grade TPE products<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Biologics and specialty injectables demand stricter closure specifications than sodium chloride or glucose LVP products. This article compares material purity, extractables and leachables, aseptic processing, lyophilization stopper design, prefilled syringe tolerances, low-temperature performance, and coated pharmaceutical closures, and introduces JSD141, a TPE material in development for biologics.<\/p>\n","protected":false},"author":5,"featured_media":4529,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[85],"tags":[],"class_list":["post-4530","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Biologics and Specialty Injectables: How Closure Requirements Differ from Standard LVP Products<\/title>\n<meta name=\"description\" content=\"Pharmaceutical stopper needs for protein drugs, lyophilized vials, prefilled syringes and IV fluids: extractables, cold storage, tolerance, sterilization.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.jsdpharma.com\/pt-br\/blog\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biologics and Specialty Injectables: How Closure Requirements Differ from Standard LVP Products\" \/>\n<meta property=\"og:description\" content=\"Pharmaceutical stopper needs for protein drugs, lyophilized vials, prefilled syringes and IV fluids: extractables, cold storage, tolerance, sterilization.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.jsdpharma.com\/pt-br\/blog\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\/\" \/>\n<meta property=\"og:site_name\" content=\"JSD\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-09T06:59:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-09T07:00:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.jsdpharma.com\/wp-content\/uploads\/2026\/11\/4.-Biologics-and-Specialty-Injectables-Main.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"JSD Pharma Editorial Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"JSD Pharma Editorial Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/blog\\\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/blog\\\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\\\/\"},\"author\":{\"name\":\"JSD Pharma Editorial Team\",\"@id\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/#\\\/schema\\\/person\\\/9838059123441702ddfd43ec394354b2\"},\"headline\":\"Biologics and Specialty Injectables: How Closure Requirements Differ from Standard LVP Products\",\"datePublished\":\"2026-11-09T06:59:20+00:00\",\"dateModified\":\"2026-11-09T07:00:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/blog\\\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\\\/\"},\"wordCount\":1653,\"publisher\":{\"@id\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/blog\\\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.jsdpharma.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/4.-Biologics-and-Specialty-Injectables-Main.jpg\",\"articleSection\":[\"Blog\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/blog\\\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\\\/\",\"url\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/blog\\\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\\\/\",\"name\":\"Biologics and Specialty Injectables: How Closure Requirements Differ from Standard LVP Products\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/blog\\\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/blog\\\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.jsdpharma.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/4.-Biologics-and-Specialty-Injectables-Main.jpg\",\"datePublished\":\"2026-11-09T06:59:20+00:00\",\"dateModified\":\"2026-11-09T07:00:28+00:00\",\"description\":\"Pharmaceutical stopper needs for protein drugs, lyophilized vials, prefilled syringes and IV fluids: extractables, cold storage, tolerance, sterilization.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/blog\\\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/blog\\\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/blog\\\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.jsdpharma.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/4.-Biologics-and-Specialty-Injectables-Main.jpg\",\"contentUrl\":\"https:\\\/\\\/www.jsdpharma.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/4.-Biologics-and-Specialty-Injectables-Main.jpg\",\"width\":1200,\"height\":600,\"caption\":\"Two women in lab coats collaborate on a computer, focused on their work in a laboratory setting.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/blog\\\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biologics and Specialty Injectables: How Closure Requirements Differ from Standard LVP Products\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/#website\",\"url\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/\",\"name\":\"JSD\",\"description\":\"Driving Safer, Smarter, and More Sustainable Healthcare Solutions\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/#organization\",\"name\":\"JSD\",\"url\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.jsdpharma.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/jsd-logo-square-white.png\",\"contentUrl\":\"https:\\\/\\\/www.jsdpharma.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/jsd-logo-square-white.png\",\"width\":696,\"height\":696,\"caption\":\"JSD\"},\"image\":{\"@id\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/#\\\/schema\\\/person\\\/9838059123441702ddfd43ec394354b2\",\"name\":\"JSD Pharma Editorial Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.jsdpharma.com\\\/wp-content\\\/litespeed\\\/avatar\\\/8464db4a867d1e22905d4edfc5e249fa.jpg?ver=1794823805\",\"url\":\"https:\\\/\\\/www.jsdpharma.com\\\/wp-content\\\/litespeed\\\/avatar\\\/8464db4a867d1e22905d4edfc5e249fa.jpg?ver=1794823805\",\"contentUrl\":\"https:\\\/\\\/www.jsdpharma.com\\\/wp-content\\\/litespeed\\\/avatar\\\/8464db4a867d1e22905d4edfc5e249fa.jpg?ver=1794823805\",\"caption\":\"JSD Pharma Editorial Team\"},\"description\":\"Insights and updates from JSD Pharma on trends and innovations shaping the pharmaceutical packaging industry. From packaging technologies to quality and regulatory developments, we aim to keep readers informed on what matters most in this evolving space.\",\"url\":\"https:\\\/\\\/www.jsdpharma.com\\\/pt-br\\\/author\\\/jsd_pharma_editorial_team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biologics and Specialty Injectables: How Closure Requirements Differ from Standard LVP Products","description":"Pharmaceutical stopper needs for protein drugs, lyophilized vials, prefilled syringes and IV fluids: extractables, cold storage, tolerance, sterilization.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.jsdpharma.com\/pt-br\/blog\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\/","og_locale":"pt_BR","og_type":"article","og_title":"Biologics and Specialty Injectables: How Closure Requirements Differ from Standard LVP Products","og_description":"Pharmaceutical stopper needs for protein drugs, lyophilized vials, prefilled syringes and IV fluids: extractables, cold storage, tolerance, sterilization.","og_url":"https:\/\/www.jsdpharma.com\/pt-br\/blog\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\/","og_site_name":"JSD","article_published_time":"2026-11-09T06:59:20+00:00","article_modified_time":"2026-11-09T07:00:28+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/www.jsdpharma.com\/wp-content\/uploads\/2026\/11\/4.-Biologics-and-Specialty-Injectables-Main.jpg","type":"image\/jpeg"}],"author":"JSD Pharma Editorial Team","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"JSD Pharma Editorial Team","Est. tempo de leitura":"8 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.jsdpharma.com\/pt-br\/blog\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\/#article","isPartOf":{"@id":"https:\/\/www.jsdpharma.com\/pt-br\/blog\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\/"},"author":{"name":"JSD Pharma Editorial Team","@id":"https:\/\/www.jsdpharma.com\/pt-br\/#\/schema\/person\/9838059123441702ddfd43ec394354b2"},"headline":"Biologics and Specialty Injectables: How Closure Requirements Differ from Standard LVP Products","datePublished":"2026-11-09T06:59:20+00:00","dateModified":"2026-11-09T07:00:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.jsdpharma.com\/pt-br\/blog\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\/"},"wordCount":1653,"publisher":{"@id":"https:\/\/www.jsdpharma.com\/pt-br\/#organization"},"image":{"@id":"https:\/\/www.jsdpharma.com\/pt-br\/blog\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\/#primaryimage"},"thumbnailUrl":"https:\/\/www.jsdpharma.com\/wp-content\/uploads\/2026\/11\/4.-Biologics-and-Specialty-Injectables-Main.jpg","articleSection":["Blog"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/www.jsdpharma.com\/pt-br\/blog\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\/","url":"https:\/\/www.jsdpharma.com\/pt-br\/blog\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\/","name":"Biologics and Specialty Injectables: How Closure Requirements Differ from Standard LVP Products","isPartOf":{"@id":"https:\/\/www.jsdpharma.com\/pt-br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.jsdpharma.com\/pt-br\/blog\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\/#primaryimage"},"image":{"@id":"https:\/\/www.jsdpharma.com\/pt-br\/blog\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\/#primaryimage"},"thumbnailUrl":"https:\/\/www.jsdpharma.com\/wp-content\/uploads\/2026\/11\/4.-Biologics-and-Specialty-Injectables-Main.jpg","datePublished":"2026-11-09T06:59:20+00:00","dateModified":"2026-11-09T07:00:28+00:00","description":"Pharmaceutical stopper needs for protein drugs, lyophilized vials, prefilled syringes and IV fluids: extractables, cold storage, tolerance, sterilization.","breadcrumb":{"@id":"https:\/\/www.jsdpharma.com\/pt-br\/blog\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.jsdpharma.com\/pt-br\/blog\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.jsdpharma.com\/pt-br\/blog\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\/#primaryimage","url":"https:\/\/www.jsdpharma.com\/wp-content\/uploads\/2026\/11\/4.-Biologics-and-Specialty-Injectables-Main.jpg","contentUrl":"https:\/\/www.jsdpharma.com\/wp-content\/uploads\/2026\/11\/4.-Biologics-and-Specialty-Injectables-Main.jpg","width":1200,"height":600,"caption":"Two women in lab coats collaborate on a computer, focused on their work in a laboratory setting."},{"@type":"BreadcrumbList","@id":"https:\/\/www.jsdpharma.com\/pt-br\/blog\/biologics-and-specialty-injectables-how-closure-requirements-differ-from-standard-lvp-products\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.jsdpharma.com\/pt-br\/"},{"@type":"ListItem","position":2,"name":"Biologics and Specialty Injectables: How Closure Requirements Differ from Standard LVP Products"}]},{"@type":"WebSite","@id":"https:\/\/www.jsdpharma.com\/pt-br\/#website","url":"https:\/\/www.jsdpharma.com\/pt-br\/","name":"JSD","description":"Driving Safer, Smarter, and More Sustainable Healthcare Solutions","publisher":{"@id":"https:\/\/www.jsdpharma.com\/pt-br\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.jsdpharma.com\/pt-br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/www.jsdpharma.com\/pt-br\/#organization","name":"JSD","url":"https:\/\/www.jsdpharma.com\/pt-br\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.jsdpharma.com\/pt-br\/#\/schema\/logo\/image\/","url":"https:\/\/www.jsdpharma.com\/wp-content\/uploads\/2026\/04\/jsd-logo-square-white.png","contentUrl":"https:\/\/www.jsdpharma.com\/wp-content\/uploads\/2026\/04\/jsd-logo-square-white.png","width":696,"height":696,"caption":"JSD"},"image":{"@id":"https:\/\/www.jsdpharma.com\/pt-br\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.jsdpharma.com\/pt-br\/#\/schema\/person\/9838059123441702ddfd43ec394354b2","name":"JSD Pharma Editorial Team","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.jsdpharma.com\/wp-content\/litespeed\/avatar\/8464db4a867d1e22905d4edfc5e249fa.jpg?ver=1794823805","url":"https:\/\/www.jsdpharma.com\/wp-content\/litespeed\/avatar\/8464db4a867d1e22905d4edfc5e249fa.jpg?ver=1794823805","contentUrl":"https:\/\/www.jsdpharma.com\/wp-content\/litespeed\/avatar\/8464db4a867d1e22905d4edfc5e249fa.jpg?ver=1794823805","caption":"JSD Pharma Editorial Team"},"description":"Insights and updates from JSD Pharma on trends and innovations shaping the pharmaceutical packaging industry. From packaging technologies to quality and regulatory developments, we aim to keep readers informed on what matters most in this evolving space.","url":"https:\/\/www.jsdpharma.com\/pt-br\/author\/jsd_pharma_editorial_team\/"}]}},"_links":{"self":[{"href":"https:\/\/www.jsdpharma.com\/pt-br\/wp-json\/wp\/v2\/posts\/4530","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.jsdpharma.com\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.jsdpharma.com\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.jsdpharma.com\/pt-br\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.jsdpharma.com\/pt-br\/wp-json\/wp\/v2\/comments?post=4530"}],"version-history":[{"count":0,"href":"https:\/\/www.jsdpharma.com\/pt-br\/wp-json\/wp\/v2\/posts\/4530\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.jsdpharma.com\/pt-br\/wp-json\/wp\/v2\/media\/4529"}],"wp:attachment":[{"href":"https:\/\/www.jsdpharma.com\/pt-br\/wp-json\/wp\/v2\/media?parent=4530"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.jsdpharma.com\/pt-br\/wp-json\/wp\/v2\/categories?post=4530"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.jsdpharma.com\/pt-br\/wp-json\/wp\/v2\/tags?post=4530"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}